Helen Scotch

Helen Scotch is an experienced professional in the fields of clinical and regulatory affairs, currently serving as the VP of Clinical & Regulatory at CroiValve since January 2022. Previously, Helen held the position of VP Regulatory, Quality & Clinical at TriFlo Cardiovascular Inc. and served in various regulatory roles at Abbott, including involvement with Cephea Valve Technologies. Helen's extensive career includes leadership positions at Boston Scientific, overseeing regulatory affairs for the Sadra Medical acquisition, and prior roles at Toyama Chemical Co. Helen holds a Bachelor of Science degree in Industrial Chemistry from the University of Limerick, earned between 1994 and 1998.